BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11064393)

  • 1. Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors.
    Yoshida S; Morii K
    J Surg Oncol; 2000 Oct; 75(2):131-5. PubMed ID: 11064393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
    Bien E; Balcerska A
    Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
    Jobin N; Garrel D; Bernier J
    Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of soluble interleukin-2 receptor-alpha in adenocarcinoma of the pancreas.
    Gansauge F; Steinbach G; Gansauge S; König HH; Müller J; Grünert A; Beger HG
    Cancer Lett; 1998 Dec; 134(2):193-9. PubMed ID: 10025881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
    Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
    Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
    Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
    Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
    Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis.
    Makis AC; Galanakis E; Hatzimichael EC; Papadopoulou ZL; Siamopoulou A; Bourantas KL
    J Infect; 2005 Oct; 51(3):206-10. PubMed ID: 16230217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
    El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
    Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma.
    Sobjanek M; Bien E; Zablotna M; Sokolowska-Wojdylo M; Sikorska M; Lange M; Nowicki R
    Postepy Dermatol Alergol; 2016 Aug; 33(4):263-8. PubMed ID: 27605896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke.
    Zhao H; Li F; Huang Y; Zhang S; Li L; Yang Z; Wang R; Tao Z; Han Z; Fan J; Zheng Y; Ma Q; Luo Y
    J Neuroinflammation; 2020 Aug; 17(1):237. PubMed ID: 32795376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF therapy and catheter-related Gram-positive sepsis increase serum IL-2 receptor α level and may falsely suggest a relapse in children with soft tissue sarcomas unless serum beta2-microglobulin, lactate dehydrogenase and C-reactive protein levels are determined concomitantly.
    Bien E; Balcerska A; Niedzwiecki M; Krawczyk M; Rapala M; Trzonkowski P; Stepinski J
    Cytokine; 2011 Sep; 55(3):347-52. PubMed ID: 21640605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer.
    Tartour E; Mosseri V; Jouffroy T; Deneux L; Jaulerry C; Brunin F; Fridman WH; Rodriguez J
    Lancet; 2001 Apr; 357(9264):1263-4. PubMed ID: 11418153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W; Chyczewska E
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
    Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB
    Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.